Brief: Acura Pharmaceuticals qtrly loss per share $0.19
14/11/2016 21:17
Nov 14 (Reuters) - Acura Pharmaceuticals Inc ACUR.O :
* Acura Pharmaceuticals announces third quarter 2016
financial results
* Qtrly loss per share $0.19
* Revenues for quarter were $218 thousand compared to $210
thousand in Q3 of 2015
* At October 31, 2016, had unrestricted cash and cash
equivalents of $4.2 million
Source text for Eikon: ID:nMKWQrnXGa
Further company coverage: ACUR.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way